Skip to main content
Premium Trial:

Request an Annual Quote

Leonard Kruimer, Peter Schineller

Skyline has appointed Leonard Kruimer as CFO, effective Aug. 15, and Peter Schineller as chief commercial officer, effective Aug. 1. Kruimer has more than 30 years of experience in corporate finance, planning, and strategy. He was CFO of Crucell from 1998 to 2011 when Johnson & Johnson acquired the firm. 

Schineller has 25 years of experience in the diagnostic and pharmaceutical spaces and most recently was CCO at Agendia. Prior to that, he was SVP and CCO at Alexza Pharmaceuticals. He previously held executive positions at Ventana Medical Systems and at Genoptix Medical Laboratories. He also was a co-founder of Verus Pharmaceuticals. 

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.